Related Experiment Videos
Interaction of human IgG preparations with polymorphonuclear leukocytes in vitro
Summary
Purified immunoglobulin G (IgG) activates immune cells, specifically polymorphonuclear leukocytes (PMN), in a dose-dependent manner. This immune cell activation may explain side effects associated with intravenous IgG therapy.
Area of Science:
- Immunology
- Biochemistry
Background:
- Intravenous immunoglobulin G (IVIG) is used therapeutically.
- The in vitro effects of purified IVIG on immune cells are not fully understood.
- Potential mechanisms for IVIG-related side effects require investigation.
Purpose of the Study:
- To investigate the in vitro effects of purified human immunoglobulin G (IgG) on polymorphonuclear leukocytes (PMN).
- To explore the potential role of IgG-induced PMN activation in adverse reactions to intravenous IgG therapy.
Main Methods:
- Purified human IgG was prepared using polyethylene glycol precipitation and ion exchange chromatography.
- The oxidative metabolism of PMN was assessed by measuring superoxide anion release and chemiluminescence.
- The effect of maltose on IgG-induced PMN stimulation was evaluated.
Main Results:
- Purified IgG demonstrated a dose-dependent stimulation of PMN oxidative metabolism.
- Superoxide anion release and chemiluminescence increased with IgG concentration, with effects detected at 0.001 mg/ml.
- Commercially available IgG preparations showed similar stimulatory effects.
- Addition of 10% maltose significantly reduced IgG-induced PMN stimulation.
Conclusions:
- Purified IgG can activate host phagocytic cells (PMN) in vitro without complement involvement.
- This IgG-mediated PMN activation may contribute to unexplained side effects observed during intravenous IgG infusions.
- Further research is warranted to elucidate the clinical implications of these findings.